PTSD Research Study Explores Potential Benefits of Cannabidiol (CBD)

Research Center: Department of Psychiatry, NYU Langone Health 
Location: 1 Park Avenue NY, NY 10016
Lead Researcher: Dr. Charles R. Marmar 
IRB Committee: This study has been reviewed and approved by the NYU Langone Health Institutional Review Board

About the Study

Post-Traumatic Stress Disorder (PTSD) is a difficult mental health condition. Research studies have seen that PTSD can significantly influence psychological and physical health. Studies have found that people with psychological trauma such as PTSD are at greater risk of having long-term physical medical conditions.

Researchers are continuously exploring different methods to help individuals with PTSD cope with symptoms. This research study seeks to determine the effectiveness of a new potential treatment option to reduce symptoms of PTSD. This potential option uses Cannabidiol (CBD). 

Why Participate? 

  • Participants may get this potential treatment at no cost.
  • Participants may experience improvements to their PTSD symptoms.
  • Participants may contribute valuable information that may help others struggling with PTSD in the future. 
  • Participants will be compensated up to $800 for participating in this study. 
  • Participants will be helping to advance medical and mental-health research.

Your Rights

  • If you decide to participate in the study and later feel that you no longer wish to be part of it, you can withdraw at any time.
  • Any information that you provide will be kept strictly confidential, except as required by law.
  • Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

  • Adults aged 18 to 70 years old who have been diagnosed with PTSD.
  • Must have been experiencing PTSD symptoms for at least 6 months. Symptoms include but are not limited to:
    • Reliving the traumatic event
    • Having disturbing dreams about the event
    • Avoiding situations that remind you of the event
    • Feeling upset when something reminds you of the event
    • Feeling jumpy or easily startled
    • Being unable to relax or let your guard down, even when you are in a safe situation
  • Must have at least 2 locators. Locators are either a close friend, significant other, family member who usually knows the interested adult’s whereabouts.
  • Must not have any metal implants or a condition that would make having an MRI not possible
  • Must be willing to able to attend 9 study visits at the research site and 4 phone interviews for over approximately 10-12 weeks

Key Study Details 

  • Interested individuals:
    • Must be willing to abstain from cannabinoid use (as well as any cannabinoid containing product) for the duration of the study
    • Must not have had exposure to trauma in the last 30 days. This includes any trauma experienced during police duty or military service.
    • Must not have had psychotherapy for PTSD or any other psychiatric related conditions in the past 2 months

About the Research Center:

Department of Psychiatry, NYU Langone Health 

The mission of the Department of Psychiatry at NYU Langone Health is to improve the wellbeing of our patients by providing compassionate, evidence-based mental healthcare. We offer a full continuum of services and, in recent years, have achieved national and international recognition for our outstanding quality of care and training.

Please note:
Due to the current situation with the COVID-19 pandemic, the researchers would like to assure the participants that ensuring the safety of the participants as well as the study staff is of utmost importance.

What’s Next?

  1. Click the link to enter your contact details and take the study questionnaire.
  2. If eligible, a member of the research team will contact you to discuss the study and answer any questions you may have.
Click Here to Check Your Eligibility for This Study